The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Long-term follow-up results of RTOG 0132.
D. Wang
No relevant relationships to disclose
Q. Zhang
No relevant relationships to disclose
C. D. Blanke
Consultant or Advisory Role - Novartis
Honoraria - Novartis
G. D. Demetri
Employment or Leadership Position - Kolltan Pharmaceuticals (U); N-of-One (U); Plexxikon (U); ZIOPHARM Oncology (U)
Consultant or Advisory Role - Alnylam; Amgen; ARIAD; ArQule; Bayer; Champions Biotechnology; Daiichi Sankyo; EMD Serono; Enzon; Genentech; GlaxoSmithKline; Idera Pharmaceuticals; Infinity; Johnson & Johnson; Kolltan Pharmaceuticals (U); Millennium; N-of-One (U); Novartis; Pfizer; Plexxikon; ZIOPHARM Oncology
Stock Ownership - Champions Biotechnology; Kolltan Pharmaceuticals; N-of-One ; Plexxikon
Honoraria - Novartis; Pfizer
Research Funding - ARIAD; Bristol-Myers Squibb; Daiichi Sankyo; Infinity; Johnson & Johnson; Novartis; Pfizer
Expert Testimony - Bayer (U); Infinity (U); Merck (U); Novartis (U); Pfizer (U)
M. C. Heinrich
Consultant or Advisory Role - MolecularMD
Stock Ownership - MolecularMD
Research Funding - Arog; ImClone Systems; Novartis
J. C. Watson
Honoraria - Novartis
J. P. Hoffman
No relevant relationships to disclose
S. H. Okuno
No relevant relationships to disclose
J. M. Kane
No relevant relationships to disclose
M. vonMehren
No relevant relationships to disclose
B. L. Eisenberg
Employment or Leadership Position - Novartis (U)
Consultant or Advisory Role - Novartis
Honoraria - Novartis